Background Cardiac hypertrophy is associated with elevated intracardiac angiotensin-converting enzyme activity, which may contribute to diastolic dysfunction.
Background Cardiac hypertrophy is associated with elevated intracardiac angiotensin-converting enzyme activity, which may contribute to diastolic dysfunction.
Methods and Results We infused enalaprilat (0.05 mg/min) for 15 minutes into the left coronary arteries of 20 adult patients with left ventricular (LV) hypertrophy due to aortic stenosis (mean aortic valve area, 0.7±0.2 cm2) and 10 patients with dilated cardiomyopathy (mean ejection fraction, 35+±4%) and assessed (1) simultaneous changes in LV micromanometer pressure and dimensions, (2) LV regional wall motion analyzed by the area method, and (3) Doppler flow-velocity profiles. Systemic neurohormonal activation did not occur with the selective left coronary artery infusion; there were no changes in plasma renin activity, angiotensin-converting enzyme activity, or atrial natriuretic peptide. In patients with aortic stenosis, LV end-diastolic pressure declined from 25±2 to 20±2 mm Hg (P<.05). LV pressure-volume and LV pressure-dimension relations showed downward shifts by ventriculography and echocardiography, respectively, indicating improved diastolic distensibility. Regional area change during isovolumic relaxation increased in the anterior segments perfused with enalaprilat but decreased in the inferior segments, indicating acceleration of isovolumic relaxation in the anterior segments and reciprocal shortening in the inferior segments. Regional peak filling rate increased in the anterior segments but not in the inferior segments, and the regional area stiffness constant decreased in the anterior segments but not in the inferior segments. There were no changes in heart rate, cardiac output, or right atrial pressure, excluding alterations in right ventricular/pericardial constraint. In contrast, in the patients with dilated cardiomyopathy the decrease in LV end-diastolic pressure from 22±2 to 18±2 mm Hg (P<.05) was accompanied by a significant fall in right atrial pressure (9±1 to 6±1 mm Hg), implicating alterations in pericardial constraint. The patients with dilated cardiomyopathy showed no improvement in regional diastolic relaxation, filling, or distensibility.
Conclusions Intracoronary enalaprilat at a dosage that did not cause systemic neurohormonal activation improved LV diastolic chamber distensibility and regional relaxation and filling in patients with LV hypertrophy due to aortic stenosis. In contrast, these effects of intracoronary enalaprilat on diastolic function were not observed in patients with dilated cardiomyopathy who did not have concentric hypertrophy. These observations support the hypothesis that the cardiac renin-angiotensin system is activated in patients with concentric pressure-overload hypertrophy and that this activation may contribute to impaired diastolic function. (Circulation. 1994; 90:2761 -2771 Key Words * angiotensin * enzymes * diastole hemodynamics * hypertrophy * aortic valve * stenosis L eft ventricular hypertrophy (LVH) is characterized by impaired chamber distensibility, relaxation, and early diastolic filling.1 This may be related in part to an enhanced activation of angiotensin II in the heart by cardiac angiotensin-converting enzyme (ACE). The renin-angiotensin system has been implicated as a modulator of cardiac hypertrophy2; the inhibition of ACE has been shown to prevent the development of LVH in rats3-5 and to reduce its extent in humans with pressure-overload hypertrophy.67 Cardiac ACE activity and mRNA levels are elevated in the hypertrophied ventricles of a rat model of aortic stenosis, and the increased rate of angiotensin II production is associated with severe and reversible impairment of diastolic function in the hypertrophied hearts.8 In human isolated trabecular muscle, angiotensin II has a direct effect on excitation-contraction coupling. gional peak filling rate was obtained by TIME (ms) determining the rate of maximal wall expansion in a time window starting 60 milliseconds after the maximal systolic pressurevolume ratio and ending 100 milliseconds before the next R wave. regression of the negative rate of rise of LV pressure (-dP/dt) against pressure with the use of the digitized data points from the period of isovolumic relaxation.14 For angiographic evaluation of LV volumes, ventricular silhouettes were digitized frame by frame on a video screen (cine frame rate, 50 frames per second). Premature and postpremature beats were excluded from analysis. A computer system (APU Phillips, Phillips Electronic Instruments Co) was used to derive the correction factor for x-ray magnification and calculated volumes every 20 milliseconds by applying Simpson's rule.15 Wall thickness at the LV equator was traced on the last unmasked diastolic frame and was computed for the subsequent frames assuming a constant LV mass. Midwall circumferential stress was calculated with the formula of Mirsky.16 Mean systolic wall stress was obtained by averaging data from the start to the end of ejection. Volume data were normalized using body surface area. Peak filling or ejection rates were calculated using a data-smoothing program. 17 Regional LV properties were analyzed in the subset of patients studied at the University of Louvain using the area method.18'19 To quantify regional wall motion during diastole, the LV silhouette in the right anterior oblique projection was divided into eight segments, four anterior and four inferior, with the long axis as the reference system (Fig 2A) . Because displacement of a reference point used to calculate regional area could create artifactual changes in regional wall motion, we did not analyze the apical segments (segments 4 and 5), where ventricular motion was greatest. The beginning of the isovolumic relaxation period was defined as peak -dP/dt, and the end of the isovolumic relaxation period was defined as 80 milliseconds after peak -dP/dt. The percentage regional area change during the isovolumic relaxation period for each segment was calculated by dividing the absolute change in area during the isovolumic relaxation period by the end-diastolic area ( Fig 2B) . Regional nonuniformity of LV wall motion during the isovolumic relaxation period was indicated by the SD of the percentage change in area during the isovolumic relaxation period for the six segments for each patient. For each segment, regional peak filling rate was automatically obtained by determining the rate of maximal wall expansion (mm'/s) in a time window starting 60 milliseconds after the maximal systolic pressure-volume ratio and ending 100 milliseconds before the next R wave to discard the atrial contribution ( Fig 2B) .20 The time between the previous R wave and this maximal wall expansion -the time to regional peak filling rate -was also determined. The regional area stiffness constant, ,3, was determined by use of the equation P~a A+y where P=pressure (mm Hg), A=regional area (mm2), 3=re-gional area stiffness constant (10-' mm-2), a=material constant (mm Hg), and y=asymptote (mm Hg), to the LV pressure and regional area data from minimum diastolic pressure to end diastole for each segment.
For echocardiographic evaluation of LV volumes and function, standard views were used, and recordings were made when visualization of the endocardium and epicardium of each of the cardiac chambers was optimal. The echocardiogram of one patient could not be analyzed because of poor visualization of endocardium. Using the apical four-chamber view, end-diastolic and end-systolic endocardial surfaces of the left ventricle were traced on stop-frame images using a video screen and light pen interfaced with a computerized graphic analyzer (Freeland Cardiac Workstation). Ventricular endsystolic (smallest ventricular cavity area) and end-diastolic (R-wave peak) cavity areas were calculated using the singleplane Simpson's rule methodl5 and averaged over three to five consecutive cardiac cycles. LV endocardium and epicardium and length were digitized from the two-dimensional echocardiographic parasternal short-axis view at the high chordal level and apical four-chamber views, respectively, for calculation of circumferential and meridional wall stress according to previously published formulas.2' End-systolic wall stress, end-diastolic wall stress, and peak systolic stress were calculated using the appropriate high-fidelity LV pressure and either end-diastolic or end-systolic (for both peak and end-systolic stress) measurements.21 Continuous digitization of septal and posterior wall endocardial borders of two-dimensional guided M-mode echoes of the left ventricle at the high chordal level and of simultaneously recorded high-fidelity LV pressure was used to construct pressure-dimension loops. Digitization was done at 6-to 12-millisecond intervals, depending on heart rate. Pre-and postintervention curves were displayed on the same graph to visually compare diastolic pressure-dimension relations to assess changes in LV diastolic distensibility.
Two-dimensional guided pulsed Doppler recordings were made of mitral inflow velocity from the apical four-chamber view with the cursor positioned at the midpoint of the annulus, parallel to assumed flow. Three to six consecutive flow-velocity profiles were digitized and averaged. Measurements included peak velocity of LV inflow in early diastole and accompanying atrial systole, their ratio (E to A ratio), the area under the early and atrial velocity curves, and total flow velocity area. Atrial filling fraction was calculated. (Fig 3A) . There was no significant change in LV end-diastolic volume index by either ventriculography or echocardiography (Table 2) to account for the change in LVEDP.
Global LV Diastolic Function
Global indexes of LV relaxation and filling did not change. was prolonged at 58±4 milliseconds and showed a trend toward improvement, with the greatest improvement seen in those with the most prolonged values (Fig 4) . In patients in whom baseline r was >60 milliseconds, r decreased from 77±3 to 63±3 milliseconds (P=.04) compared with those with r <60 milliseconds (47±3 to 48±3 milliseconds, P=NS). There was no change in the global LV peak filling rate, time to peak filling rate, or the E to A ratio.
To assess the effect of regional enalaprilat infusion on global LV distensibility, relations of LV diastolic pressure to LV volume and LV dimension were analyzed (Fig 5) . Despite the fact that only the anterior region of the LV myocardium was exposed to the enalaprilat infusion, downward shifts in the global relations between LV diastolic pressure and volume and LV diastolic pressure and dimension were observed in 11 of 19 patients who were administered the drug. Overall, significant downward shifts in the relations between LV diastolic pressure and volume and LV diastolic pressure and dimension were observed with ventriculography and echocardiography, respectively. Regional LV Diastolic Function
The regional area change during isovolumic relaxation increased significantly in the anterior segments but decreased in the inferior segments (Fig 6, Table 3 ), indicating the occurrence of enhanced segmental early relaxation during the isovolumic relaxation period in the region of myocardium that was perfused with intracoronary enalaprilat. Because total LV volume must remain constant during the isovolumic relaxation period, these data show that relaxation was asynchronous, with initial acceleration of relaxation in the anterior segments perfused with enalaprilat and reciprocal change in the inferior segments. Regional nonuniformity of LV wall motion during the isovolumic relaxation period (ie, SD of the percentage change in area of the six ventriculogram segments for each patient) increased from 4.0±0.6% to 5.8+0.6% (P<.05). There was an inverse correlation (r= -.87) between the increase in regional dyssynchrony (resulting from acceleration of relaxation in the anterior segment) and the change in global peak filling rate. Thus, patients with the largest increase in regional dyssynchrony had decreases in global peak filling rate, while patients with smaller increases in asynchrony had improvement in global peak filling rate.
Regional peak filling rate increased in the anterior segments perfused with enalaprilat but not in the inferior segments (Table 3 ). Time to regional peak filling rate decreased in the anterior segments but not in the inferior segments (Table 3) . Plots of LV pressure versus regional area for each segment were used to calculate f3.
In the anterior segments, j3 decreased significantly but did not in the inferior segments (Table 3) .
Linear regression analyses showed that there was no significant correlation between changes in global or regional relaxation parameters and any index of systolic load, including LV systolic pressure, end-systolic wall stress, and systemic vascular resistance.
Infusion of vehicle had no significant effect on regional area change during isovolumic relaxation (anterior, 1.1±1.4% to -0.4±2.3% of end-diastolic area; inferior, -0.1±3.3% to 1.5±2.7% of end-diastolic area; NS) or change in regional peak filling rate (anterior change, -86±97 mm2.* -* m-2; inferior change, -340+160 MM2 * S-1 * 2; NS).
Dilated Cardiomyopathy Hemodynamic Response to Intracoronary Enalaprilat
As with the aortic stenosis group (Table 1) , LVEDP was elevated (22±1 mm Hg) and r was markedly prolonged (101±7 milliseconds) at baseline in the patients with dilated cardiomyopathy who were administered enalaprilat. Intracoronary enalaprilat did not change LV systolic pressure but caused a significant fall in LVEDP (from 22±2 to 18±2 mm Hg). In contrast to the aortic stenosis group, pulmonary arterial pressure and right atrial pressure also fell significantly in the dilated cardiomyopathy group, implicating changes in right ventricular pressure and relaxation of pericardial constraint as a cause for the changes in LV diastolic function. Fig 7 shows that the percentage change in LVEDP correlated closely with the percentage change in right atrial pressure for the dilated cardiomyopathy group (r=.7) but not the aortic stenosis group (r=.1).
LV Diastolic Function
Global indexes of left ventricular relaxation and filling did not change ( Table 2 ). The global LV pressure-volume relation did not shift downward as it did in the aortic stenosis group (Fig 8) , indicating that the decrease in LVEDP that was observed resulted from a reduction in LV volume and movement along the same pressure-volume relation rather than from a downward shift in the curve. There was also no improvement in regional area change during isovolumic relaxation, regional peak filling rate, time to regional peak filling rate, or regional area stiffness constant (Table 3) .
Plasma Neurohormones
There was no significant change in plasma renin activity, ACE activity, epinephrine, norepinephrine, aldosterone, or atrial natriuretic peptide in response to the intracoronary enalaprilat infusion in either the aortic stenosis or the dilated cardiomyopathy group (Table 4) .
Discussion
The purpose of the present study was to assess whether the local inhibition of the cardiac renin-angiotensin system would result in improvement in abnormal LV diastolic properties in patients with severe concentric pressure-overload hypertrophy due to aortic stenosis. A novel observation of this study is that global LV distensibility improves with infusion of enalaprilat into the left coronary artery of patients with aortic stenosis. Improvement in global isovolumic relaxation was most pronounced in patients with the most prolonged base- isovolumic LV diastolic pressure in the nonhypertrophied control group, it caused a significant, dose-dependent increase in LV isovolumic diastolic pressure in the hypertrophied hearts with the high level of ACE expression. 8 Furthermore, in recent studies the adverse effects of local cardiac angiotensin II activation on diastolic function in hypertrophied hearts were prevented by specific inhibition of ACE.39 Global Versus Regional Analysis of Diastolic Function The infusion of enalaprilat into the left coronary arteries of patients with aortic stenosis resulted in a fall in LVEDP and improvements in all measures of regional anterior wall diastolic function: regional isovolumic relaxation of the anterior wall, regional peak filling rate, time to regional peak filling rate, and f. Improvement in global parameters of diastolic function, however, was seen in the patients with the most prominent baseline elevation of LVEDP and prolongation of the isovolumic relaxation time constant, r. This is consistent with a recent preliminary observation that intracoronary enalaprilat had a negligible effect on diastolic function in patients with only mild dysfunction.40 It also suggests, as in animal models,8 that diastolic dysfunction is due in part to activation of the cardiac renin-angiotensin system in patients with higher diastolic pressures and more delayed relaxation.
The greater sensitivity of the regional analysis over the global analysis in our study was likely due to the acceleration of relaxation in the anterior wall, which would tend to improve both relaxation and filling but which leads to dyssynchronous relaxation, which buffered the global improvement in relaxation and filling.41,42 The relative advantage of regional anterior diastolic relaxation was partially offset by the mechanical disadvantage of dyssynchronous function. Global peak filling rate and regional dyssynchrony of relaxation were inversely correlated (r= -.87); patients who developed the least dyssynchrony exhibited the largest increase in global peak filling rate. While global measures of isovolumic relaxation and early diastolic filling did not show improvement, a measure of mid-and late-di-0 1 . (Fig 5) . We chose to determine LV volumes by echocardiography in addition to ventriculography to exclude the potential confounding effects of contrast injection. Because the same method was used in a given patient and all data collection was paired, possible differences between the two techniques could not influence our findings. Our regional analysis, however, relied on angiographic determinations alone. To minimize errors caused by manual tracing of the contours, a frame-byframe analysis was used and regional motion was computed after data smoothing. 20 We believe that our findings of improved regional diastolic function in the aortic stenosis group are strengthened by the presence of two control groups (the patients with aortic stenosis who received vehicle and those with dilated cardiomyopathy who received enalaprilat). First, no changes in global or regional diastolic function were observed in the control group of patients with aortic stenosis who received vehicle rather than enalaprilat. Second, in the dilated cardiomyopathy cohort, no changes in regional diastolic function were noted despite a fall in LVEDP that was due to alterations in right heart loading. While the ideal control group would consist of age-matched subjects without LVH, these subjects do not routinely undergo diagnostic catheterization in contemporary practice and are not available for study using intracoronary infusion techniques at our institutions.
Mechanisms for Improvement in Diastolic Function
Although the mechanism by which intracoronary enalaprilat improved diastolic function in patients with pressure-overload hypertrophy is not known, we propose that the improved diastolic function was due to inhibition of intracardiac ACE, which led to a localized 50 Enalaprilat has no effect on low-flow ischemia in nonhypertrophied control hearts but significantly attenuates the accentuated ischemic diastolic dysfunction in hypertrophied hearts, and this beneficial effect on ischemia cannot be explained by differences in coronary blood flow.50 Thus, it is possible that ACE inhibition, independent of coronary vasodilatation, may ameliorate the diastolic abnormalities attributable to subendocardial hypoperfusion in these hypertrophied hearts. The absence of effects of intracoronary enalaprilat on global or regional relaxation in dilated cardiomyopathy reinforces our arguments that indirect mechanisms such as a regional "garden hose" effect are not responsible for the changes observed in aortic stenosis. Moreover, we have previously injected 0.1 mg of nitroglycerin into the left main artery of a small number of patients with concentric hypertrophy and we did not observe an alteration in the time course of isovolumic relaxation or a change in synchrony of the anterior and posterior walls (H.P., M.F.R., unpublished data, 1982).
Lastly, it is possible that the mechanism by which intracoronary enalaprilat improves diastolic function is independent of the renin-angiotensin system; ACE is identical to kininase II, which metabolizes bradykinin. Blunted degradation of bradykinin could improve diastolic function through either direct coronary vasodilation or modulation of endothelial-myocardial coupling, which has been shown to affect relaxation in isolated papillary muscle preparations. 53, 54 While the mechanism by which intracoronary enalaprilat improved diastolic function in our patients with aortic stenosis is unclear, it is unlikely that the observed improvement in diastolic dysfunction was attributable to a systemic effect of the intracoronary enalaprilat. First, there were no significant measurable systemic neurohormonal changes. Second, in these patients but not in those with dilated cardiomyopathy, right atrial pressure did not change, which excludes alterations in right ventricular-pericardial constraint as a cause for changes in LV diastolic function and the downward shift in the LV pressure-volume relation. Third, although there was a small but significant decrease in LV systolic pressure, 55 
